NO983508L - Antiglukortikoidmedikament - Google Patents
AntiglukortikoidmedikamentInfo
- Publication number
- NO983508L NO983508L NO983508A NO983508A NO983508L NO 983508 L NO983508 L NO 983508L NO 983508 A NO983508 A NO 983508A NO 983508 A NO983508 A NO 983508A NO 983508 L NO983508 L NO 983508L
- Authority
- NO
- Norway
- Prior art keywords
- aliphatic
- pheromones
- drugs
- mammalian cells
- carbon atoms
- Prior art date
Links
- 230000000694 effects Effects 0.000 abstract 3
- 239000003016 pheromone Substances 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003862 glucocorticoid Substances 0.000 abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 210000004962 mammalian cell Anatomy 0.000 abstract 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical class C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Securing Of Glass Panes Or The Like (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU96101194/14A RU2125446C1 (ru) | 1996-01-31 | 1996-01-31 | Антиглюкокортикоидное лекарственное средство |
| PCT/RU1996/000028 WO1997027845A1 (en) | 1996-01-31 | 1996-02-01 | Antiglucocorticoid drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983508D0 NO983508D0 (no) | 1998-07-30 |
| NO983508L true NO983508L (no) | 1998-07-30 |
Family
ID=20175968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983508A NO983508L (no) | 1996-01-31 | 1998-07-30 | Antiglukortikoidmedikament |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5965623A (pt) |
| EP (1) | EP0896819A4 (pt) |
| JP (1) | JPH11504946A (pt) |
| KR (1) | KR100347862B1 (pt) |
| CN (1) | CN1213964A (pt) |
| AU (1) | AU710479B2 (pt) |
| BG (1) | BG102709A (pt) |
| BR (1) | BR9612470A (pt) |
| CA (1) | CA2244985A1 (pt) |
| CZ (1) | CZ160598A3 (pt) |
| EE (1) | EE9800209A (pt) |
| GE (1) | GEP20001955B (pt) |
| HU (1) | HUP9900504A2 (pt) |
| LT (1) | LT4441B (pt) |
| LV (1) | LV12177B (pt) |
| MD (1) | MD1430B1 (pt) |
| MX (1) | MX9806182A (pt) |
| NO (1) | NO983508L (pt) |
| PL (1) | PL187564B1 (pt) |
| RU (1) | RU2125446C1 (pt) |
| SI (1) | SI9620053A (pt) |
| SK (1) | SK65598A3 (pt) |
| UA (1) | UA48212C2 (pt) |
| WO (1) | WO1997027845A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001039766A2 (en) * | 1999-12-01 | 2001-06-07 | Alydar Pharmaceuticals Ltd. | Screening invertebrate pheromones for therapeutic activity |
| US6548706B2 (en) * | 1999-12-23 | 2003-04-15 | Aerojet Fine Chemicals Llc | Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| EP1409656A4 (en) * | 2001-03-12 | 2005-01-12 | Darley Pharmaceuticals Ltd | SCREENING OF PHEROMONAL COMPOUNDS OF NON-STEROID AND NON-PEPTIDE INVERTEBRATE HAVING ACTIVITY MODULATING MITOGEN-ACTIVATED PROTEIN KINASE |
| US6806293B1 (en) | 2001-03-12 | 2004-10-19 | Darley Pharmaceuticals Ltd | Use of pheromone compounds having MAP kinase modulating activity |
| RU2211213C2 (ru) * | 2001-05-16 | 2003-08-27 | Закрытое Акционерное Общество "Асгл - Исследовательские Лаборатории" | Лекарственное средство, обладающее противоязвенным, кардиопротективным и противошоковым действием |
| AU2003225277A1 (en) * | 2002-05-02 | 2003-11-17 | Robert Harris | Lipid removal from the body |
| RU2222326C1 (ru) * | 2002-10-09 | 2004-01-27 | Российский онкологический научный центр им. Н.Н.Блохина РАМН | Способ лечения саркомы юинга |
| US6752649B2 (en) * | 2002-11-07 | 2004-06-22 | Xentris, Llc | Illuminated indicia power supply apparatus and method of manufacture |
| DE10335845B4 (de) * | 2003-05-09 | 2006-08-31 | Müller, Martina, Dr.med. | Pheromone als Antikrebsmittel |
| KR100556335B1 (ko) * | 2004-02-05 | 2006-03-03 | 정만길 | 6알-(3,6-디데옥시-엘-아라비노-헥소피라노실옥시)헵타노익산, 그 제조방법 및 그를 포함하는 장기휴면 유발효과 |
| US20110195501A1 (en) * | 2008-08-06 | 2011-08-11 | Pangu Gautam D | Ultrasonically induced release from polymer vesicles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US161926A (en) | 1875-04-13 | Improvement in ink-wells | ||
| US2900756A (en) * | 1958-12-09 | 1959-08-25 | Jacobson Martin | Attractants for the gypsy moth |
| EP0149847A3 (en) * | 1983-12-26 | 1989-11-08 | Eisai Co., Ltd. | Therapeutic and preventive agent containing dolichol |
| JPH0759504B2 (ja) * | 1986-01-23 | 1995-06-28 | エーザイ株式会社 | ポリプレニルアルコ−ル含有注射剤 |
| US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
| US4740627A (en) * | 1987-05-21 | 1988-04-26 | Phillips Petroleum Company | Synthesis of E,Z-11-tetradecen-1-al |
| CA1331137C (en) | 1988-02-29 | 1994-08-02 | Pfizer, Inc. | Transdermal flux enhancing compositions |
| US5190978A (en) * | 1989-09-29 | 1993-03-02 | Dai-Ichi Kogyo Seiyaku Co. Ltd. | Carcinostatic compositions and methods |
| FR2718354B1 (fr) * | 1994-04-08 | 1996-05-03 | Roussel Uclaf | Application des composés antiglucocorticoïde pour la préparation de médicaments destinés à la prévention ou au traitement des manifestations liées au syndrome de sevrage des narcotiques et les compositions les renfermant. |
-
1996
- 1996-01-02 UA UA98074187A patent/UA48212C2/uk unknown
- 1996-01-31 RU RU96101194/14A patent/RU2125446C1/ru not_active IP Right Cessation
- 1996-02-01 CZ CZ981605A patent/CZ160598A3/cs unknown
- 1996-02-01 PL PL96322596A patent/PL187564B1/pl unknown
- 1996-02-01 MD MD98-0171A patent/MD1430B1/ro unknown
- 1996-02-01 US US08/930,733 patent/US5965623A/en not_active Expired - Fee Related
- 1996-02-01 SK SK655-98A patent/SK65598A3/sk unknown
- 1996-02-01 EE EE9800209A patent/EE9800209A/xx unknown
- 1996-02-01 BR BR9612470A patent/BR9612470A/pt not_active Application Discontinuation
- 1996-02-01 SI SI9620053A patent/SI9620053A/sl not_active IP Right Cessation
- 1996-02-01 AU AU46363/96A patent/AU710479B2/en not_active Ceased
- 1996-02-01 CA CA002244985A patent/CA2244985A1/en not_active Abandoned
- 1996-02-01 GE GEAP19964288A patent/GEP20001955B/en unknown
- 1996-02-01 EP EP96902026A patent/EP0896819A4/en not_active Withdrawn
- 1996-02-01 CN CN96180161A patent/CN1213964A/zh active Pending
- 1996-02-01 JP JP9527525A patent/JPH11504946A/ja active Pending
- 1996-02-01 KR KR10-1998-0705074A patent/KR100347862B1/ko not_active Expired - Fee Related
- 1996-02-01 WO PCT/RU1996/000028 patent/WO1997027845A1/ru not_active Ceased
- 1996-02-01 HU HU9900504A patent/HUP9900504A2/hu unknown
-
1998
- 1998-04-21 LT LT98-054A patent/LT4441B/lt not_active IP Right Cessation
- 1998-05-28 LV LVP-98-126A patent/LV12177B/lv unknown
- 1998-07-30 NO NO983508A patent/NO983508L/no unknown
- 1998-07-31 MX MX9806182A patent/MX9806182A/es unknown
- 1998-08-20 BG BG102709A patent/BG102709A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA48212C2 (uk) | 2002-08-15 |
| CN1213964A (zh) | 1999-04-14 |
| NO983508D0 (no) | 1998-07-30 |
| KR100347862B1 (ko) | 2003-01-24 |
| AU710479B2 (en) | 1999-09-23 |
| KR19990076946A (ko) | 1999-10-25 |
| MX9806182A (es) | 1998-10-31 |
| PL322596A1 (en) | 1998-02-02 |
| WO1997027845A1 (en) | 1997-08-07 |
| RU2125446C1 (ru) | 1999-01-27 |
| EP0896819A1 (en) | 1999-02-17 |
| LT4441B (lt) | 1999-01-25 |
| EP0896819A4 (en) | 2001-11-07 |
| HUP9900504A2 (en) | 1999-09-28 |
| CA2244985A1 (en) | 1997-08-07 |
| AU4636396A (en) | 1997-08-22 |
| BG102709A (bg) | 1999-06-30 |
| SK65598A3 (en) | 1998-09-09 |
| CZ160598A3 (cs) | 1998-08-12 |
| LV12177B (lv) | 1999-06-20 |
| JPH11504946A (ja) | 1999-05-11 |
| SI9620053A (sl) | 1998-04-30 |
| PL187564B1 (pl) | 2004-08-31 |
| EE9800209A (et) | 1998-12-15 |
| LT98054A (en) | 1998-10-26 |
| LV12177A (lv) | 1998-12-20 |
| BR9612470A (pt) | 1999-07-13 |
| MD1430B1 (ro) | 2000-03-31 |
| GEP20001955B (en) | 2000-03-05 |
| US5965623A (en) | 1999-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Neptune Jr et al. | Labile fatty acids of rat diaphragm muscle and their possible role as the major endogenous substrate for maintenance of respiration | |
| NO983508L (no) | Antiglukortikoidmedikament | |
| ES2176502T3 (es) | Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion. | |
| Rios et al. | Analgesic activity of affinin, an alkamide from Heliopsis longipes (Compositae) | |
| KR910018020A (ko) | 프라바스타틴과 피브르산 유도체의 혼합제. 및 이 혼합제를 사용한 이상지혈증 치료 방법 | |
| LV12766A (lv) | Composition of l-dopa esters | |
| DE68913476D1 (de) | Kosmetisches Präparat. | |
| AU8329982A (en) | Derivatives of c-076 compounds | |
| KR900017590A (ko) | 좌창(Acne)치료방법 및 그 약제 조성물 | |
| Yanighara et al. | Rapid analysis of small samples containing forskolin using monoclonal antibodies | |
| DE3866408D1 (de) | Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs. | |
| CO4980849A1 (es) | Composiciones farmaceuticas -2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona(la mivudina), y su uso en terapia medica | |
| McIsaac et al. | New metabolites of serotonin in carcinoid urine | |
| ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. | |
| Koraćević et al. | Effect of trypsin, S-adenosylmethionine and ethionine on L-serine sulfhydrase activity | |
| Cleland | Auxin-induced methylation in maize | |
| Driedger et al. | Non‐phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts | |
| Wood et al. | Effect of di-n-propylacetate and γ-acetylenic GABA on hyperbaric oxygen-induced seizures and GABA metabolism | |
| Victor et al. | Mechanical inhibition of hypocotyl elongation induces radial enlargement: implications for cytokinin action | |
| US5753697A (en) | Method and pharmaceutical compositions containing rosmanol derivatives | |
| Batra et al. | Are there cyclic variations in estradiol secretion in the non-pregnant rabbit? | |
| Rouillier et al. | Influence of a dominant follicle atresia and estradiol release by ovarian follicles during superovulation in cattle | |
| KR830006251A (ko) | 2-클로로-4-트리플루오로메틸-티아졸 카보티오산 및 그의 유도체 | |
| DE59801586D1 (de) | Zur topischen applikation bestimmte diclofenac-lösung | |
| LU81501A1 (fr) | Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques |